Clinical Trials
3
Active:0
Completed:1
Trial Phases
3 Phases
Phase 2:1
Phase 3:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (33.3%)Phase 2
1 (33.3%)Phase 3
1 (33.3%)Nutritional Intervention With the Dietary Supplement, Immunocal® in MCI Patients: Promotion of Brain Health
Not Applicable
- Conditions
- Mild Cognitive Impairment (MCI)
- First Posted Date
- 2018-02-27
- Last Posted Date
- 2021-02-10
- Lead Sponsor
- Immunotec Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT03448055
- Locations
- 🇨🇦
Memory Clinic/Jewish General Hospital, Montréal, Quebec, Canada
Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients
Phase 3
Terminated
- Conditions
- NON-SMALL CELL LUNG CANCER
- First Posted Date
- 2010-01-12
- Last Posted Date
- 2015-01-21
- Lead Sponsor
- Immunotec Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT01046383
- Locations
- 🇨🇦
British Columbia Cancer Agency, Vancouver, British Columbia, Canada
🇨🇦Juravinski Cancer Centre, Hamilton, Ontario, Canada
🇨🇦CHUM - Hopital Notre Dame, Montreal, Quebec, Canada
Effect of Immunocal® With Exercise Versus Casein With Exercise on Aging Processes in Elderly Persons
Phase 2
Completed
- Conditions
- SarcopeniaAging
- First Posted Date
- 2009-07-09
- Last Posted Date
- 2021-02-09
- Lead Sponsor
- Immunotec Inc.
- Target Recruit Count
- 99
- Registration Number
- NCT00935610
- Locations
- 🇨🇦
Institut de recherches cliniques de Montréal, Montreal, Quebec, Canada
News
No news found